@Loftus

Wall Street Journal @WSJ reporter - pharmaceuticals, medical devices, healthcare. [email protected]. Author of The Messenger

 Philadelphia
peteloftus.com
Joined July 2008
  • Tweets5.3K
  • Following2.3K
  • Followers19.4K
91Media
“Not for the squeamish.” The Mütter Museum has been collecting human body parts for 160 years. A tumor its donor named “Helga the Destroyer” is stuck in storage while the museum debates its future. Don't miss this @Loftus Ahed! wsj.com/lifestyle/mutter-mus… @WSJ #philanthropy#museum

Battle Erupts Over Mütter Museum’s Gutsy Displays, Including the ‘Mega Colon’

The not-for-the-squeamish medical museum of the human body and its ailments has put a hold on new exhibits, rattling donors.

wsj.com
1
2
1
8
2,500
Peter Loftus retweeted
Aaron Zitner@aaronzitner1 Apr 2023
Friends of a free press: Please read and share our article about Evan Gershkovich of The Wall Street Journal, the distinguished U.S. journalist unjustly detained by Russia. wsj.com/articles/wsj-reporte….

Evan Gershkovich Loved Russia, the Country That Turned on Him

The correspondent, whose parents fled the Soviet Union, made Moscow a second home. He was detained Wednesday by the FSB for alleged espionage, an allegation the Journal vehemently denies.

wsj.com
4
16
1
29
9,557
Editors of more than three dozen news organizations signed a letter calling for the release of Wall Street Journal reporter Evan Gershkovich #IStandwithEvan wsj.com/articles/leaders-of-… via @WSJ

Leaders of Top Global News Organizations Call for Release of Wall Street Journal Reporter Evan...

The editors condemned Mr. Gershkovich’s detention in a letter to the Russian ambassador to the U.S.

wsj.com
1
7
2,137
Breaking: Drugmaker Sanofi plans to cut the prices of its insulin products by up to 78% and cap the cost for patients taking one of the products at $35 a month. wsj.com/articles/diabetes-dr…

Diabetes Drug Giant Sanofi Cuts Insulin Prices by Up to 78%

French drugmaker Sanofi said it would cut the price of some of its insulin products by as much as 78% in the U.S., joining other big diabetes drugmakers facing pressure over high costs.

wsj.com
3
3
3,193
Novartis AG notified doctors it cannot fill new orders for a drug shown to extend lives of advanced prostate cancer patients. Some patients have no other treatment option. “People will die from this shortage, for sure,” Dr. Jonathan McConathy said. wsj.com/articles/shortage-of…

Shortage of Last-Ditch Drug for Advanced Prostate Cancer Worries Doctors

Novartis seeks to ramp up production of the drug, Pluvicto, to ease supply issues.

wsj.com
2
20
3
16
9,381
Breaking: Novo Nordisk, a large insulin maker, plans to cut the prices of its widely used products up to 75% to make them more affordable for patients, ⁦@Loftus⁩ reports wsj.com/articles/insulin-pri…

WSJ News Exclusive | Novo Nordisk to Slash Insulin Prices by Up to 75%

It is the latest move by a drugmaker to make steep reductions in list prices amid pressure to curb diabetes-treatment costs.

wsj.com
18
3
35
45,681
Big news day including comprehensive coverage of SVB, but I’d also like to single out some great work by my WSJ Health & Science colleagues featured prominently on WSJ.com right now...
1
4
1,513
more replies
Struggles to find a permanent head of the important NIH, from @l_e_whyte and @StephArmour1 : wsj.com/articles/nih-top-job…

WSJ News Exclusive | NIH Top Job Still Empty as Candidates Back Out

The White House has struggled to find a candidate after Francis Collins retired from the role in December 2021.

wsj.com
2
1
3
6,379
The Journal podcast about testing drugs for fentanyl featuring @littlewern wsj.com/podcasts/the-journal…
1
1,208
Please tune in tomorrow for this live Q&A with @jonathanrockoff to discuss ‘The Messenger,' my book about Moderna wsj.com/live-qa/peter-loftus…

Live Question & Answer Event - Peter Loftus on His New Book, ‘The Messenger’ - WSJ.com

In his new book, author and WSJ reporter Peter Loftus describes how Moderna went from a beleaguered biotech firm to developing one of the first Covid-19 vaccines. The author sits down with Jonathan...

wsj.com
4
6
1,703
Feb. 7! WSJ reporter/author Peter @Loftus and WSJ health biz editor @jonathanrockoff discuss Peter's new book about Moderna and the Covid-19 vaccine. Watch here: wsj.com/live-qa #WSJHealth
7
2
10
2,500
Rain? What rain? Good morning San Francisco, gearing up for #JPM23
6
1
66
12,740
Physicians are reporting unseasonably high numbers of respiratory illnesses in kids, straining many children’s hospitals before the typically busier winter months wsj.com/articles/a-surge-in-… via @WSJ @Brabbott42 @jdeavila

Surge in Pediatric Respiratory Viruses, Including RSV, Strains Children’s Hospitals

RSV and other respiratory illnesses in children are climbing well before the typical busy winter season.

wsj.com
1
8
5
A respiratory virus, RSV, is a main culprit. Companies are racing to make vaccines against it: wsj.com/articles/gsk-poised-…

GSK Poised for Pfizer Battle in RSV Vaccine Market

The British pharmaceutical giant said its experimental vaccine against respiratory syncytial virus sharply reduced the risk of disease in a key trial, paving the way for a contest with Pfizer in what...

wsj.com
1
1
1
3
For years RSV eluded efforts to find a vaccine, but an NIH research breakthrough helped set the stage for the current crop of candidates: wsj.com/articles/pfizer-mode…

Pfizer, Moderna, J&J See Respiratory Virus RSV as Next Vaccine Target

The respiratory virus, which has been among the top causes of U.S. hospitalizations for decades, is one of the last remaining childhood diseases without an approved vaccine.

wsj.com
3
Vaccine experts advising the CDC recommended the agency add Covid-19 vaccines to its lists of shots recommended for adults and children wsj.com/articles/covid-19-va… via @dmosbergen

Covid-19 Vaccines Should Be Among Regular Immunizations, CDC Advisers Say

If the Centers for Disease Control and Prevention follows the guidance of its advisory panel, the shots would be part of the agency’s lists of recommended inoculations for adults and children.

wsj.com
2
2
4
More breaking FDA news from me: FDA has authorized use of Novavax’s Covid-19 vaccine as a booster for adults wsj.com/articles/fda-authori…

FDA Authorizes Novavax Covid-19 Shot as Booster for Adults

The shot can be administered at least six months after the completion of a primary vaccination.

wsj.com
4
12
2
20
Breaking: Health experts advising the FDA recommended the agency pull the Makena treatment to prevent preterm births, after agency staff said most studies didn’t find the drug worked, ⁦@l_e_whyte⁩ reports wsj.com/articles/fda-adviser…

FDA Advisers Recommend Pulling Drug to Prevent Preterm Births From Market

The obstetricians and other reproductive-health experts voted after various studies found the drug didn’t provide a benefit but did increase the risk of blood clots and other side effects.

wsj.com
1
2
Load more